Authors
Sachin Anil Ghag, Hsuan-Yeh Pan, Shreyasi Ganguly, Viviane Souza de Campos, Subashree Murugan, Gregory Schmidt, Jessica M Skeie, Mark A Greiner, Samuel Herberg, Rajalekshmy Shyam
Published in
The American journal of pathology. Nov 12, 2026. Epub Nov 12, 2026.
Abstract
Fuchs' Endothelial Corneal Dystrophy (FECD), a degenerative corneal disorder, is marked by the thickening of Descemet's membrane and a progressive loss of corneal endothelial cells, ultimately leading to vision loss. A feature associated with the disease is the reduced stiffness of Descemet's membrane. However, the effects of this change in Descemet's membrane, on corneal endothelial cell health are not well understood. This study explored how changes in substrate stiffness and the signaling pathways associated with these changes influence corneal endothelial functions. In bovine corneal endothelial cells cultured on soft substrate, there was significant increase of p-FAK, endothelial-to-mesenchymal transition (EndMT) markers, mitochondrial dysfunction, and apoptosis. In the Col8a2Q455K/Q455K FECD mouse model, increased p-FAK Y397 levels coincided with the onset of phenotypes. Intraperitoneal injections of a p-FAK inhibitor in Col8a2Q455K/Q455K FECD mouse model did not improve the FECD-associated phenotypes. This study reveals that changes in substrate stiffness can elicit molecular changes in the corneal endothelial cells, which have implications in FECD pathogenesis.
PMID:
43014672
Bibliographic data and abstract were imported from PubMed on 12 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 12
- Comments 0